1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones...

Details 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones... 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones...

2005-09-20

2005-09-20

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S234000

Reexamination Certificate

active

06946463

ABSTRACT:
Compounds according to structural diagram (I)are disclosed, wherein R1, A, E and D are as defined in the specification. Also disclosed are pharmaceutical compositions comprising a pain-ameliorating effective amount of a compound in accord with structural diagram (I).The following is an examiner's statement of reasons for allowance: In view of applicants' amendments to the claims which limit “E” to phenyl or cycloalkyl groups the rejections of the previous action no longer pertain as they at best teach “E” as alkyl.

REFERENCES:
patent: 2003/0153571 (2003-08-01), Brown et al.
patent: 2003/0162783 (2003-08-01), Alford et al.
patent: 2004/0053930 (2004-03-01), Brown et al.
patent: 0736531 (1996-10-01), None
patent: WO 9511244 (1995-04-01), None
patent: WO 0147523 (2001-07-01), None
patent: WO 0147524 (2001-07-01), None
patent: WO 0147923 (2001-07-01), None
patent: WO 0147924 (2001-07-01), None
patent: WO 0147925 (2001-07-01), None
patent: 2002/026740 (2002-04-01), None

Affiliated with

Also associated with

Rating

1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3437955